erus BioSciences(CHRS) - 2024 Q1 - Quarterly Report

In connection with the Sale Transaction, the Company and Sandoz entered into a Transition Services Agreement ("TSA"), pursuant to which the Company is providing certain business support services on behalf of Sandoz including billings, collections, and the remittance of rebates, to ensure business continuity for patients and customers for a period not expected to extend beyond December 31, 2024. Under the TSA, the Company is entitled to be reimbursed for its costs and has recorded income of $0.3 million for ...